Total Payments
$4,700
2024 Payments
$783.99
Companies
22
Transactions
348
Medicare Patients
2,033
Medicare Billing
$149,619
Payment Breakdown by Category
Food & Beverage$4,431 (94.3%)
Education$269.02 (5.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,431 | 344 | 94.3% |
| Education | $269.02 | 4 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $1,640 | 177 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $565.38 | 42 | $0 (2024) |
| ABBVIE INC. | $556.59 | 34 | $0 (2024) |
| GENZYME CORPORATION | $499.53 | 24 | $0 (2024) |
| Lilly USA, LLC | $361.61 | 19 | $0 (2024) |
| PFIZER INC. | $200.23 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $184.05 | 9 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $171.77 | 6 | $0 (2024) |
| Amgen Inc. | $130.69 | 6 | $0 (2024) |
| Galderma Laboratories, L.P. | $104.37 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $783.99 | 41 | Janssen Biotech, Inc. ($178.44) |
| 2023 | $809.77 | 50 | Janssen Biotech, Inc. ($363.35) |
| 2022 | $1,059 | 83 | GENZYME CORPORATION ($225.00) |
| 2021 | $470.00 | 43 | Janssen Biotech, Inc. ($185.51) |
| 2020 | $112.90 | 6 | Janssen Biotech, Inc. ($44.68) |
| 2019 | $582.57 | 47 | Janssen Biotech, Inc. ($155.35) |
| 2018 | $576.38 | 51 | Janssen Biotech, Inc. ($340.49) |
| 2017 | $305.96 | 27 | Janssen Biotech, Inc. ($183.93) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Immunology | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: DERMATOLOGY | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immunology | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: Immunology | ||||||
| 09/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Immunology | ||||||
| 08/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: Immunology | ||||||
| 08/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.02 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: Immunology | ||||||
| 08/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $6.45 | General |
| Category: Immunology | ||||||
| 07/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Immunology | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Immunology | ||||||
| 07/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: DERMATOLOGY | ||||||
| 07/08/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Immunology | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $39.24 | General |
| Category: Immunology | ||||||
| 06/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $71.58 | General |
| 06/13/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Dermatology | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Immunology | ||||||
| 06/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/30/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Immunology | ||||||
| 05/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.81 | General |
| Category: Dermatology | ||||||
| 05/02/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.97 | General |
| 04/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 75 | $24,885 | $5,821 |
| 2022 | 2 | 27 | 29 | $7,755 | $2,450 |
| 2021 | 17 | 1,021 | 1,799 | $268,237 | $79,223 |
| 2020 | 14 | 934 | 1,664 | $220,489 | $62,125 |
Total Patients
2,033
Total Services
3,567
Medicare Billing
$149,619
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 51 | $18,710 | $4,352 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 24 | $6,175 | $1,470 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 17 | $5,201 | $1,680 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 12 | $2,555 | $769.82 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 134 | 205 | $54,735 | $17,859 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 189 | 253 | $46,552 | $15,016 | 32.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 102 | 127 | $34,544 | $9,620 | 27.8% |
| 17000 | Destruction of skin growth | Office | 2021 | 123 | 159 | $25,440 | $6,100 | 24.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 136 | 158 | $17,538 | $5,851 | 33.4% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 96 | 641 | $9,615 | $3,078 | 32.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $10,556 | $3,020 | 28.6% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 41 | 43 | $10,492 | $2,450 | 23.4% |
| 11401 | Removal of growth (0.6 to 1.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 22 | 23 | $8,625 | $2,309 | 26.8% |
| 11301 | Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | Office | 2021 | 23 | 26 | $7,722 | $2,057 | 26.6% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 19 | 21 | $6,447 | $1,954 | 30.3% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 13 | 15 | $5,805 | $1,810 | 31.2% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 13 | 13 | $5,629 | $1,806 | 32.1% |
| 17261 | Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | Office | 2021 | 14 | 17 | $6,052 | $1,648 | 27.2% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 35 | 36 | $6,696 | $1,576 | 23.5% |
| 17281 | Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | Office | 2021 | 12 | 13 | $5,694 | $1,547 | 27.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $6,095 | $1,523 | 25.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 234 | 306 | $68,496 | $19,641 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 147 | 227 | $33,006 | $9,147 | 27.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 76 | 95 | $22,016 | $6,269 | 28.5% |
| 17000 | Destruction of skin growth | Office | 2020 | 108 | 149 | $20,879 | $5,340 | 25.6% |
About Dr. Joseph Bikowski, MD
Dr. Joseph Bikowski, MD is a Dermatology healthcare provider based in Sewickley, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053305920.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Bikowski, MD has received a total of $4,700 in payments from pharmaceutical and medical device companies, with $783.99 received in 2024. These payments were reported across 348 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,431).
As a Medicare-enrolled provider, Bikowski has provided services to 2,033 Medicare beneficiaries, totaling 3,567 services with total Medicare billing of $149,619. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Clinical & Laboratory Dermatological Immunology
- Location Sewickley, PA
- Active Since 09/07/2005
- Last Updated 01/12/2012
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053305920
Products in Payments
- REMICADE (Biological) $768.50
- DUPIXENT (Biological) $651.86
- TREMFYA (Drug) $573.43
- COSENTYX (Biological) $488.74
- SKYRIZI (Biological) $380.51
- TALTZ (Drug) $341.78
- Tremfya (Drug) $242.95
- EUCRISA (Drug) $200.23
- Otezla (Drug) $115.05
- Humira (Biological) $99.89
- RINVOQ (Biological) $59.58
- STELARA (Biological) $55.03
- COSENTYX (Drug) $53.67
- BOTOX COSMETIC (Biological) $53.29
- Sotyktu (Drug) $36.88
- Winlevi (Drug) $35.70
- EPIDUO FORTE (Drug) $32.79
- DUPIXENT (Drug) $31.72
- ILUMYA (Biological) $29.65
- OPZELURA (Drug) $28.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.